Suchergebnisse - "Janus Kinase Inhibitors"

Immunohistochemical Characterization of JAK Family Expression in the Primary Inflammatory Infiltrate of Lichen Planopilaris and Folliculitis Decalvans, With an Exploratory Clinical Assessment of Oral JAK Inhibitors.

Autoren: Lasheras-Pérez MA Garrido-Ruiz MC Lobato-Berezo A et al.

Quelle: International journal of dermatology [Int J Dermatol] 2025 Dec; Vol. 64 (12), pp. 2266-2273. Date of Electronic Publication: 2025 Sep 29.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Blackwell Science Country of Publication: England NLM ID: 0243704 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-4632 (Electronic) Linking ISSN: 00119059 NLM ISO Abbreviation: Int J Dermatol Subsets: MEDLINE

MeSH-Schlagworte: Lichen Planus*/drug therapy , Lichen Planus*/pathology , Folliculitis*/drug therapy , Folliculitis*/pathology , Janus Kinase Inhibitors*/therapeutic use , Janus Kinase Inhibitors*/adverse effects , Janus Kinase Inhibitors*/administration & dosage , Alopecia*/drug therapy , Alopecia*/pathology , Scalp Dermatoses*/drug therapy , Scalp Dermatoses*/pathology, Humans ; Male ; Female ; Retrospective Studies ; Middle Aged ; Adult ; Immunohistochemistry ; Janus Kinase 1/metabolism ; Janus Kinase 1/analysis ; Janus Kinase 1/antagonists & inhibitors ; Janus Kinase 2/metabolism ; Janus Kinase 2/analysis ; Janus Kinase 2/antagonists & inhibitors ; Janus Kinase 3/metabolism ; Janus Kinase 3/analysis ; Janus Kinase 3/antagonists & inhibitors ; Administration, Oral ; Aged ; Case-Control Studies ; Scalp/pathology ; Young Adult ; Severity of Illness Index ; Abnormalities, Multiple ; Eyebrows/abnormalities ; Darier Disease

SCR Disease Name: Lichen planus follicularis; Burnett Schwartz Berberian syndrome

Janus kinase inhibitors and biologics for treatment of livedoid vasculopathy: a systematic review.

Autoren: Liu Y Li T Shi W

Quelle: The Journal of dermatological treatment [J Dermatolog Treat] 2025 Dec; Vol. 36 (1), pp. 2451804. Date of Electronic Publication: 2025 Jan 19.

Publikationsart: Journal Article; Systematic Review

Info zur Zeitschrift: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-1753 (Electronic) Linking ISSN: 09546634 NLM ISO Abbreviation: J Dermatolog Treat Subsets: MEDLINE

MeSH-Schlagworte: Biological Products*/adverse effects , Biological Products*/therapeutic use , Biological Products*/administration & dosage , Janus Kinase Inhibitors*/adverse effects , Janus Kinase Inhibitors*/therapeutic use , Janus Kinase Inhibitors*/administration & dosage , Livedoid Vasculopathy*/drug therapy, Humans ; Treatment Outcome

Understanding the effects of Janus kinase inhibitors on the cardiovascular system in comparison to main biological DMARDs in rheumatoid arthritis.

Autoren: Zavoriti A Miossec P

Quelle: Autoimmunity reviews [Autoimmun Rev] 2025 Nov 28; Vol. 24 (11), pp. 103892. Date of Electronic Publication: 2025 Jul 26.

Publikationsart: Journal Article; Review

Info zur Zeitschrift: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101128967 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-0183 (Electronic) Linking ISSN: 15689972 NLM ISO Abbreviation: Autoimmun Rev Subsets: MEDLINE

MeSH-Schlagworte: Arthritis, Rheumatoid*/drug therapy , Arthritis, Rheumatoid*/complications , Arthritis, Rheumatoid*/immunology , Janus Kinase Inhibitors*/therapeutic use , Janus Kinase Inhibitors*/adverse effects , Janus Kinase Inhibitors*/pharmacology , Antirheumatic Agents*/therapeutic use , Antirheumatic Agents*/adverse effects , Antirheumatic Agents*/pharmacology , Cardiovascular Diseases*/etiology , Cardiovascular System*/drug effects , Cardiovascular System*/metabolism , Biological Products*/therapeutic use, Humans ; Cytokines/metabolism ; Janus Kinases/antagonists & inhibitors ; Janus Kinases/metabolism ; Signal Transduction/drug effects ; Animals

Efficacy and safety of tofacitinib treatment in Finnish patients with juvenile idiopathic arthritis: a real-life study.

Autoren: Levälampi T Rebane K Mikola K et al.

Quelle: Arthritis research & therapy [Arthritis Res Ther] 2025 Oct 31; Vol. 27 (1), pp. 201. Date of Electronic Publication: 2025 Oct 31.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: BioMed Central Country of Publication: England NLM ID: 101154438 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-6362 (Electronic) Linking ISSN: 14786354 NLM ISO Abbreviation: Arthritis Res Ther Subsets: MEDLINE

MeSH-Schlagworte: Arthritis, Juvenile*/drug therapy , Pyrimidines*/therapeutic use , Pyrimidines*/adverse effects , Piperidines*/therapeutic use , Piperidines*/adverse effects , Janus Kinase Inhibitors*/therapeutic use , Janus Kinase Inhibitors*/adverse effects , Protein Kinase Inhibitors*/therapeutic use , Protein Kinase Inhibitors*/adverse effects, Humans ; Male ; Female ; Finland ; Child ; Treatment Outcome ; Child, Preschool ; Adolescent

Topical Ruxolitinib and Delgocitinib Versus Systemic JAK Inhibitors: A Comparative Safety Review.

Autoren: Böll SL Seyed Jafari SM Conrad C et al.

Quelle: International journal of molecular sciences [Int J Mol Sci] 2025 Oct 30; Vol. 26 (21). Date of Electronic Publication: 2025 Oct 30.

Publikationsart: Journal Article; Review; Comparative Study

Info zur Zeitschrift: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

MeSH-Schlagworte: Pyrazoles*/administration & dosage , Pyrazoles*/adverse effects , Pyrazoles*/pharmacokinetics , Pyrazoles*/therapeutic use , Janus Kinase Inhibitors*/administration & dosage , Janus Kinase Inhibitors*/adverse effects , Janus Kinase Inhibitors*/pharmacokinetics , Janus Kinase Inhibitors*/therapeutic use , Skin Diseases*/drug therapy, Humans ; Nitriles ; Pyrimidines ; Administration, Topical

Comparative risk of uveitis with Janus kinase inhibitors versus tumor necrosis factor inhibitors in ankylosing spondylitis and psoriatic diseases: a target trial emulation study.

Autoren: Bai WH Liao PL Bai YC et al.

Quelle: Frontiers in immunology [Front Immunol] 2025 Oct 24; Vol. 16, pp. 1673970. Date of Electronic Publication: 2025 Oct 24 (Print Publication: 2025).

Publikationsart: Journal Article; Comparative Study

Info zur Zeitschrift: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

MeSH-Schlagworte: Spondylitis, Ankylosing*/drug therapy , Spondylitis, Ankylosing*/epidemiology , Uveitis*/epidemiology , Uveitis*/etiology , Tumor Necrosis Factor Inhibitors*/adverse effects , Tumor Necrosis Factor Inhibitors*/therapeutic use , Janus Kinase Inhibitors*/adverse effects , Janus Kinase Inhibitors*/therapeutic use , Arthritis, Psoriatic*/drug therapy , Psoriasis*/drug therapy, Humans ; Female ; Male ; Adult ; Middle Aged ; Incidence ; Risk Factors

Comprehensive disproportionality analysis of individual case safety reports associated with Janus kinase inhibitors in psoriasis and psoriatic arthritis using the FAERS database.

Autoren: Deng K Jiang H Xie S et al.

Quelle: Frontiers in immunology [Front Immunol] 2025 Oct 02; Vol. 16, pp. 1629886. Date of Electronic Publication: 2025 Oct 02 (Print Publication: 2025).

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

MeSH-Schlagworte: Janus Kinase Inhibitors*/adverse effects , Janus Kinase Inhibitors*/therapeutic use , Arthritis, Psoriatic*/drug therapy , Psoriasis*/drug therapy , Adverse Drug Reaction Reporting Systems*, Humans ; Female ; Male ; Middle Aged ; Adult ; Retrospective Studies ; Pharmacovigilance ; Databases, Factual ; Aged ; Piperidines/adverse effects ; Pyrimidines/adverse effects ; United States ; Pyrroles/adverse effects ; United States Food and Drug Administration ; Young Adult ; Heterocyclic Compounds, 3-Ring

NK cell cytotoxicity is markedly reduced in younger patients with RA treated with JAK inhibitors.

Autoren: Akagi T Nishimura Y Fujita S et al.

Quelle: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2025 Oct 01; Vol. 64 (10), pp. 5404-5412.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE

MeSH-Schlagworte: Killer Cells, Natural*/drug effects , Killer Cells, Natural*/immunology , Janus Kinase Inhibitors*/therapeutic use , Janus Kinase Inhibitors*/adverse effects , Arthritis, Rheumatoid*/drug therapy , Arthritis, Rheumatoid*/immunology , Cytotoxicity, Immunologic*/drug effects , Antirheumatic Agents*/therapeutic use, Humans ; Female ; Male ; Middle Aged ; Adult ; Aged ; Age Factors ; Tumor Necrosis Factor Inhibitors/therapeutic use

Therapeutic drug monitoring of Janus kinase inhibitors for precision dosing: where do we stand ?

Autoren: Tachet J Marzolini C Decosterd LA et al.

Quelle: Expert review of clinical pharmacology [Expert Rev Clin Pharmacol] 2025 Oct; Vol. 18 (10), pp. 1-17. Date of Electronic Publication: 2025 Nov 06.

Publikationsart: Journal Article; Review

Info zur Zeitschrift: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101278296 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1751-2441 (Electronic) Linking ISSN: 17512433 NLM ISO Abbreviation: Expert Rev Clin Pharmacol Subsets: MEDLINE

MeSH-Schlagworte: Janus Kinase Inhibitors*/administration & dosage , Janus Kinase Inhibitors*/adverse effects , Janus Kinase Inhibitors*/pharmacokinetics , Janus Kinase Inhibitors*/pharmacology , Drug Monitoring*/methods, Humans ; Dose-Response Relationship, Drug ; Precision Medicine/methods ; Animals ; Myeloproliferative Disorders/drug therapy ; Autoimmune Diseases/drug therapy

Targeting the JAK/STAT pathway in palmoplantar pustulosis: a review.

Autoren: Vimbai Chirindo C Yun-Jie W Tauseef H et al.

Quelle: Annals of medicine [Ann Med] 2025 Dec; Vol. 57 (1), pp. 2594352. Date of Electronic Publication: 2025 Dec 01.

Publikationsart: Journal Article; Review

Info zur Zeitschrift: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8906388 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2060 (Electronic) Linking ISSN: 07853890 NLM ISO Abbreviation: Ann Med Subsets: MEDLINE

MeSH-Schlagworte: Janus Kinase Inhibitors*/therapeutic use , Janus Kinase Inhibitors*/pharmacology , Janus Kinase Inhibitors*/adverse effects , Psoriasis*/drug therapy , Janus Kinases*/antagonists & inhibitors , Janus Kinases*/metabolism , STAT Transcription Factors*/metabolism , STAT Transcription Factors*/antagonists & inhibitors, Humans ; Signal Transduction/drug effects ; Pyrimidines/therapeutic use ; Piperidines/therapeutic use ; Treatment Outcome ; Azetidines ; Purines ; Pyrazoles ; Sulfonamides

Kimura disease responded well to tofacitinib in three cases.

Autoren: Cao M Xiao Y Wang Y

Quelle: The Journal of dermatological treatment [J Dermatolog Treat] 2025 Dec; Vol. 36 (1), pp. 2591481. Date of Electronic Publication: 2025 Nov 24.

Publikationsart: Journal Article; Case Reports

Info zur Zeitschrift: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-1753 (Electronic) Linking ISSN: 09546634 NLM ISO Abbreviation: J Dermatolog Treat Subsets: MEDLINE

MeSH-Schlagworte: Piperidines*/therapeutic use , Piperidines*/administration & dosage , Pyrimidines*/therapeutic use , Pyrimidines*/administration & dosage , Pyrroles*/therapeutic use , Pyrroles*/administration & dosage , Janus Kinase Inhibitors*/therapeutic use , Janus Kinase Inhibitors*/administration & dosage , Kimura Disease*/drug therapy , Kimura Disease*/pathology , Kimura Disease*/diagnosis , Protein Kinase Inhibitors*/therapeutic use , Protein Kinase Inhibitors*/administration & dosage, Humans ; Male ; Treatment Outcome ; Female ; Adult ; Middle Aged

When JAK inhibitors are off the table: durable remission of severe alopecia areata with dexamethasone oral mini-pulse and a focused review.

Autoren: Shanshal M; Department of Dermatology, Imperial College Healthcare NHS Trust, London, United Kingdom.

Quelle: The Journal of dermatological treatment [J Dermatolog Treat] 2025 Dec; Vol. 36 (1), pp. 2589031. Date of Electronic Publication: 2025 Nov 16.

Publikationsart: Journal Article; Case Reports; Review

Info zur Zeitschrift: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-1753 (Electronic) Linking ISSN: 09546634 NLM ISO Abbreviation: J Dermatolog Treat Subsets: MEDLINE

MeSH-Schlagworte: Alopecia Areata*/drug therapy , Alopecia Areata*/immunology , Alopecia Areata*/diagnosis , Janus Kinase Inhibitors*/administration & dosage , Janus Kinase Inhibitors*/therapeutic use , Dexamethasone*/administration & dosage , Glucocorticoids*/administration & dosage, Humans ; Female ; Middle Aged ; Pulse Therapy, Drug ; Treatment Outcome ; Remission Induction/methods ; Administration, Oral ; Lupus Erythematosus, Systemic/complications ; Lupus Erythematosus, Systemic/immunology ; Kidney Transplantation ; Severity of Illness Index

Intermittent and Short-Term Empirical Ruxolitinib Regimen for Steroid-Refractory Flareups of Fibrodysplasia Ossificans Progressiva.

Autoren: Chen RL Yang TH Wang YH et al.

Quelle: Pharmacology research & perspectives [Pharmacol Res Perspect] 2025 Dec; Vol. 13 (6), pp. e70193.

Publikationsart: Journal Article; Case Reports

Info zur Zeitschrift: Publisher: John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States NLM ID: 101626369 Publication Model: Print Cited Medium: Internet ISSN: 2052-1707 (Electronic) Linking ISSN: 20521707 NLM ISO Abbreviation: Pharmacol Res Perspect Subsets: MEDLINE

MeSH-Schlagworte: Pyrazoles*/administration & dosage , Pyrazoles*/therapeutic use , Pyrazoles*/adverse effects , Myositis Ossificans*/drug therapy , Janus Kinase Inhibitors*/administration & dosage , Janus Kinase Inhibitors*/therapeutic use , Janus Kinase Inhibitors*/adverse effects, Humans ; Nitriles ; Adolescent ; Female ; Pyrimidines

308 nm Excimer Laser Combined With JAK Inhibitors for Adult Localized Non-Segmental Vitiligo: A Multicenter Randomized Controlled Trial.

Autoren: Qi Z Zhang L Chang S et al.

Quelle: International journal of dermatology [Int J Dermatol] 2025 Dec; Vol. 64 (12), pp. 2283-2291. Date of Electronic Publication: 2025 Jul 19.

Publikationsart: Journal Article; Randomized Controlled Trial; Multicenter Study

Info zur Zeitschrift: Publisher: Blackwell Science Country of Publication: England NLM ID: 0243704 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-4632 (Electronic) Linking ISSN: 00119059 NLM ISO Abbreviation: Int J Dermatol Subsets: MEDLINE

MeSH-Schlagworte: Vitiligo*/therapy , Janus Kinase Inhibitors*/therapeutic use , Janus Kinase Inhibitors*/adverse effects , Lasers, Excimer*/therapeutic use , Lasers, Excimer*/adverse effects , Sulfonamides*/therapeutic use , Azetidines*/therapeutic use , Low-Level Light Therapy*/methods, Humans ; Male ; Female ; Adult ; Middle Aged ; Treatment Outcome ; Combined Modality Therapy/methods ; Young Adult ; Purines/therapeutic use ; Dermoscopy ; Skin Pigmentation/radiation effects ; Skin Pigmentation/drug effects ; Recurrence ; Severity of Illness Index ; Pyrazoles

Tofacitinib successful treatment of idiopathic twenty-nail dystrophy: a case report.

Autoren: Zhao W Shan S Liu D

Quelle: The Journal of dermatological treatment [J Dermatolog Treat] 2025 Dec; Vol. 36 (1), pp. 2562314. Date of Electronic Publication: 2025 Sep 25.

Publikationsart: Case Reports; Journal Article

Info zur Zeitschrift: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-1753 (Electronic) Linking ISSN: 09546634 NLM ISO Abbreviation: J Dermatolog Treat Subsets: MEDLINE

MeSH-Schlagworte: Piperidines*/therapeutic use , Piperidines*/administration & dosage , Pyrimidines*/therapeutic use , Pyrimidines*/administration & dosage , Nail Diseases*/drug therapy , Nail Diseases*/pathology , Nail Diseases*/diagnosis , Pyrroles*/therapeutic use , Pyrroles*/administration & dosage , Janus Kinase Inhibitors*/therapeutic use , Janus Kinase Inhibitors*/administration & dosage , Protein Kinase Inhibitors*/therapeutic use, Humans ; Treatment Outcome ; Female ; Male ; Middle Aged ; Administration, Oral

JAK Inhibitors for the Treatment of Vitiligo: Current Evidence and Emerging Therapeutic Potential.

Autoren: Ferreira C King B Torres T

Quelle: Drugs [Drugs] 2025 Dec; Vol. 85 (12), pp. 1521-1534. Date of Electronic Publication: 2025 Sep 25.

Publikationsart: Journal Article; Review

Info zur Zeitschrift: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 7600076 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1950 (Electronic) Linking ISSN: 00126667 NLM ISO Abbreviation: Drugs Subsets: MEDLINE

MeSH-Schlagworte: Vitiligo*/drug therapy , Janus Kinase Inhibitors*/therapeutic use , Janus Kinase Inhibitors*/pharmacology , Janus Kinase Inhibitors*/administration & dosage , Janus Kinases*/antagonists & inhibitors , Janus Kinases*/metabolism, Humans ; Nitriles ; Signal Transduction/drug effects ; Pyrazoles/therapeutic use ; Pyrimidines

Cardiovascular and thromboembolic risks of JAK inhibitors in atopic dermatitis: A global cohort study.

Autoren: Kridin K Kridin S Mayer E et al.

Quelle: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2025 Dec; Vol. 39 (12), pp. 2088-2095. Date of Electronic Publication: 2025 Jul 21.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3083 (Electronic) Linking ISSN: 09269959 NLM ISO Abbreviation: J Eur Acad Dermatol Venereol Subsets: MEDLINE

MeSH-Schlagworte: Dermatitis, Atopic*/drug therapy , Janus Kinase Inhibitors*/adverse effects , Janus Kinase Inhibitors*/therapeutic use , Thromboembolism*/chemically induced , Thromboembolism*/epidemiology , Pulmonary Embolism*/epidemiology , Pulmonary Embolism*/chemically induced, Humans ; Female ; Male ; Middle Aged ; Adult ; Methotrexate/therapeutic use ; Methotrexate/adverse effects ; Antibodies, Monoclonal, Humanized/adverse effects ; Antibodies, Monoclonal, Humanized/therapeutic use ; Cohort Studies ; Myocardial Infarction/epidemiology ; Myocardial Infarction/chemically induced ; Stroke/epidemiology ; Stroke/chemically induced ; Cyclosporine/therapeutic use ; Cyclosporine/adverse effects ; Venous Thrombosis/epidemiology ; Venous Thrombosis/chemically induced ; Incidence

Tofacitinib in combination with glucocorticoids in the treatment of eosinophilic granulomatosis with polyangiitis: a pilot study of 11 cases.

Autoren: Liu Y Zhan M Chen R et al.

Quelle: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2025 Dec 01; Vol. 64 (12), pp. 6294-6301.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE

MeSH-Schlagworte: Pyrimidines*/therapeutic use , Pyrimidines*/administration & dosage , Piperidines*/therapeutic use , Piperidines*/administration & dosage , Piperidines*/adverse effects , Glucocorticoids*/therapeutic use , Glucocorticoids*/administration & dosage , Janus Kinase Inhibitors*/therapeutic use , Janus Kinase Inhibitors*/administration & dosage , Granulomatosis with Polyangiitis*/drug therapy , Churg-Strauss Syndrome*/drug therapy, Humans ; Female ; Male ; Middle Aged ; Pilot Projects ; Drug Therapy, Combination ; Adult ; Treatment Outcome ; Prospective Studies ; Aged ; Remission Induction

Clinical Characteristics and 1-Year Response in Rheumatic Mexican Patients Using JAK Inhibitors: Data From BIOBADAMEX.

Autoren: Rivera-Terán V Colunga-Pedraza IJ Vega-Morales D et al.

Quelle: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases [J Clin Rheumatol] 2025 Dec 01; Vol. 31 (8), pp. 319-324. Date of Electronic Publication: 2025 Aug 15.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9518034 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-7355 (Electronic) Linking ISSN: 10761608 NLM ISO Abbreviation: J Clin Rheumatol Subsets: MEDLINE

MeSH-Schlagworte: Janus Kinase Inhibitors*/adverse effects , Janus Kinase Inhibitors*/therapeutic use , Janus Kinase Inhibitors*/administration & dosage , Heterocyclic Compounds, 3-Ring*/adverse effects , Heterocyclic Compounds, 3-Ring*/therapeutic use , Heterocyclic Compounds, 3-Ring*/administration & dosage , Arthritis, Rheumatoid*/drug therapy , Rheumatic Diseases*/drug therapy , Rheumatic Diseases*/epidemiology, Humans ; Mexico/epidemiology ; Female ; Male ; Middle Aged ; Piperidines/adverse effects ; Piperidines/therapeutic use ; Piperidines/administration & dosage ; Azetidines/adverse effects ; Azetidines/therapeutic use ; Azetidines/administration & dosage ; Pyrazoles/adverse effects ; Pyrazoles/therapeutic use ; Pyrazoles/administration & dosage ; Adult ; Registries ; Pyrimidines/adverse effects ; Pyrimidines/therapeutic use ; Pyrimidines/administration & dosage ; Sulfonamides/adverse effects ; Sulfonamides/therapeutic use ; Sulfonamides/administration & dosage ; Purines/adverse effects ; Purines/therapeutic use ; Purines/administration & dosage ; Treatment Outcome ; Aged ; Antirheumatic Agents/therapeutic use

Oral tofacitinib for generalized Dowling-Degos disease with refractory pruritus: a case report.

Autoren: Yang L Jing M Ruan Z et al.

Quelle: The Journal of dermatological treatment [J Dermatolog Treat] 2025 Dec; Vol. 36 (1), pp. 2516716. Date of Electronic Publication: 2025 Jun 17.

Publikationsart: Journal Article; Case Reports

Info zur Zeitschrift: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-1753 (Electronic) Linking ISSN: 09546634 NLM ISO Abbreviation: J Dermatolog Treat Subsets: MEDLINE

MeSH-Schlagworte: Pruritus*/drug therapy , Pruritus*/etiology , Pruritus*/diagnosis , Piperidines*/administration & dosage , Piperidines*/therapeutic use , Pyrimidines*/administration & dosage , Pyrimidines*/therapeutic use , Pyrroles*/administration & dosage , Pyrroles*/therapeutic use , Janus Kinase Inhibitors*/administration & dosage , Janus Kinase Inhibitors*/therapeutic use, Humans ; Male ; Middle Aged ; Administration, Oral ; Treatment Outcome ; Acitretin/administration & dosage ; Acitretin/adverse effects ; Severity of Illness Index